LAT and non-small cell lung carcinoma: Addressing these gaps, future studies will refine the role of LAT in combination with systemic therapies and drive more effective and personalized treatment strategies for oligoprogressive NSCLC, leading to an improved survival and quality of life in this unique patient population.